PlainRecalls

Fougera Pharmaceuticals, Inc.

Compiled from official public sources by the publisher.

8 recalls on record · Latest: Mar 29, 2017

Subscribe to new Fougera Pharmaceuticals, In… recalls (RSS)

Agency notice ledger

Federal filing book Fougera Pharmaceuticals, In… LIGHT-BOOK · SINGLE-AGENCY

#1,739 of 14,151 · 8 notices · 0.008% archive

  • BOOK 8 notices
  • RANK #1,739 of 14,151
  • SHARE 0.008% archive
  • AGENCY FDA Drug (8)
  • CAT drugs
  • CATS 3 categories
  • LATEST Mar 29, 2017
  • PHOTO Ab Sciex

Nearest notice-volume peer: Ab Sciex (0 notice gap)

Fougera Pharmaceuticals, Inc. accounts for about 0.008% of the 104,423-notice archive on 8 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Fougera Pharmaceuticals, In… compares to 14,151 recalling firms

Fougera Pharmaceuticals, Inc. ranks 1,739th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Fougera Pharmaceuticals, In… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

8 1739th of 14151 higher than 12,296 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Fougera Pharmaceuticals, In… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Fougera Pharmaceuticals, Inc. holds about 0.008% of archive notices alongside 8 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Mar 29, 2017

Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60
FDA Drug Moderate Nov 19, 2014

FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET WT 60 grams tubes, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0135-15 (15 g) and NDC 0168-0135-60 (60 g)
FDA Drug Low Jul 23, 2014

Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. Fougera & Co, A Division of Fougera Pharmaceuticals Inc., Melville, New York, 11747, NDC 0168-0336-60.
FDA Drug Low Jul 23, 2014

Triamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. Fougera & Co, A Division of Fougera Pharmaceuticals Inc., Melville, New York, 11747, NDC 0168-0337-60.
FDA Drug Low Mar 19, 2014

Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.
FDA Drug Low Feb 5, 2014

KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-30, UPC 3 0168-0099-30 9.
FDA Drug Low Apr 10, 2013

Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-15
FDA Drug Low Aug 1, 2012

Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.

Fougera Pharmaceuticals, In… holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (8 here).

Ab Sciex 8 Acumedia Manufacturers, Inc. 8 Adept Medical Ltd 8 Aju Pharm Co., Ltd. 8 Ambriola Co., Inc., The 8

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

American Regent, Inc. 8 Burel Pharmaceuticals Inc 8 Daiichi Sankyo Pharma Development 8 Drug Depot, Inc., dba Aps Pharmacy 8

Frequently Asked Questions

How many federal recall notices name Fougera Pharmaceuticals, In…? ▼
PlainRecalls indexes 8 distinct federal recall events naming Fougera Pharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Fougera Pharmaceuticals, In… sit among other recalling firms? ▼
Fougera Pharmaceuticals, Inc. ranks #1,739 of 14,151 by distinct recall-event count among 14,151 firms in this archive (87th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Fougera Pharmaceuticals, In…'s notices? ▼
FDA Drug accounts for 8 of this firm's 8 indexed notices.
What product category dominates Fougera Pharmaceuticals, In…'s filing book? ▼
Filings for Fougera Pharmaceuticals, Inc. span 3 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Fougera Pharmaceuticals, Inc.: 8 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Fougera Pharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026